论文部分内容阅读
肝移植作为暴发型肝炎的治疗方法之一,近年来,逐渐受到关注。一般说来,暴发型肝炎内科治疗效果不佳,生存率仪20%左右。最近由于开展了肝移植,其生存率已达到54～74%。目前认为,呈亚急性经过的重症肝炎是肝移植的良好适应症,但适应标准尚无一致意见。一般认为,应在出现进行性肝昏迷、脑水肿、肾功能不全以及低血压等直接影响生命预后的合并症之前,确定肝移植的适应症。英国(伦敦)皇家大学医院(KCH)对多例暴发型
Liver transplantation as one of the treatment of fulminant hepatitis, in recent years, gradually received attention. In general, fulminant hepatitis medical treatment ineffective, about 20% survival rate instrument. Recently, due to carry out liver transplantation, its survival rate has reached 54 to 74%. Currently, subacute passes severe hepatitis is a good indication for liver transplantation, but there is no consensus to adapt to the standard. It is generally believed that indications of liver transplantation should be identified before complications such as progressive hepatic coma, cerebral edema, renal insufficiency, and hypotension, which directly affect the prognosis of life. Royal (UK) Royal Hospital Hospital (KCH) against multiple outbreaks